Topic Editors

Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, 1678 Dong Fang Road, Shanghai 200127, China
Dr. Jiong Hu
Shanghai Institute of Hematology, Department of Hematology, Blood & Marrow Transplantation Center, Collaborative Innovation Center of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Outcomes of Hematopoietic Stem Cell Transplantation in Patients with Leukemia

Abstract submission deadline
31 October 2026
Manuscript submission deadline
31 December 2026
Viewed by
11

Topic Information

Dear Colleagues,

Leukemia remains a significant threat to global health, and its treatment has long served as a pioneer in oncology research. Despite recent breakthroughs in immunotherapy and targeted therapy, hematopoietic stem cell transplantation (HSCT) remains the most potent curative option for high-risk or refractory leukemia, serving as a cornerstone of hematological care. However, current HSCT protocols are often associated with significant toxicity and adverse effects, which limit the broader application of this technology. Consequently, optimizing transplantation systems, refining patient selection, reducing transplant-related mortality (TRM), and mitigating relapse rates have become critical priorities for improving outcomes.

For this Topic, we invite original articles and comprehensive reviews that showcase the latest advances in HSCT, specifically focusing on reduced toxicity and improved efficacy. We specifically encourage submissions focused on the following:

  • Optimizing conditioning regimens.
  • Reducing viral and fungal infection rates.
  • Lowering transplant-related mortality.
  • Managing the intensity of GVHD.
  • Strategies for preventing recurrence and improving overall survival.

Overall, this Topic aims to highlight recent advances in anti-leukemic strategies and their potential impact on clinical practice and patient outcomes. We eagerly anticipate your valuable contributions to this vital field of study.

Prof. Dr. Jing Chen
Dr. Jiong Hu
Topic Editors

Keywords

  • leukemia
  • hematopoietic stem cell transplantation
  • indication
  • donor
  • conditioning
  • transplant-related mortality
  • relapse
  • outcome

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Cancers
cancers
4.4 8.8 2009 19.1 Days CHF 2900 Submit
Current Oncology
curroncol
3.4 4.9 1994 22.8 Days CHF 2200 Submit
Onco
onco
- - 2021 23.7 Days CHF 1000 Submit
Transplantology
transplantology
- 1.4 2020 29.2 Days CHF 1200 Submit

Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.

MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:

  1. Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
  2. Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
  3. Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
  4. Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
  5. Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.

Published Papers

This Topic is now open for submission.
Back to TopTop